Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
Abstract Atypical teratoid rhabdoid tumor (ATRT) is an aggressive embryonal brain tumor among infants and young children. Two challenges exist for preclinical testing in ATRT. First, genetically quiet, ATRT is a difficult tumor to target molecularly. Tumor cells need to divide to propagate tumor gro...
Guardado en:
Autores principales: | M. Tarek Elghetany, Jia-Min Ho, Lois Hew Shi-Qi, Sekar Karthik, Jack M. F. Su, Qi Lin, YuChen Du, Jianhe Shen, Wing-Yuk Chow, Ching C. Lau, Adekunle Adesina, Angela Major, Anat Erdreich-Epstein, Kam-Man Hui, Xiao-Nan Li, Wan-Yee Teo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de5f4ee8efbe4626bc463e33bc5fd9a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Modelling the microenvironment of the most aggressive brain tumours for preclinical studies
por: Juš Žavbi, et al.
Publicado: (2021) -
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma
por: Markus Steiner, et al.
Publicado: (2021) -
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
por: Chow M, et al.
Publicado: (2016) -
Teaching the Design and Fabrication of RPD Frameworks With a Digital Workflow: A Preclinical Dental Exercise
por: Ahmed Mahrous, et al.
Publicado: (2020) -
Human Papillomavirus: From Basic Science to Clinical Management for Preclinical Medical Students
por: Rachel Wiley, et al.
Publicado: (2018)